ASAnna Veronica Silven

Anna Veronica Silven

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna Veronica Silven has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Smartphone-Based Cardiovascular Health Assessment in Adults in the Netherlands: Prospective Cohort Study (Preprint)

    by Jasper Wilhelmus Adrianus van Egeraat, Anna V Silven, Niels Chavannes, Tobias N. Bonten

  • Open Access

    Smartphone-based assessment of physical activity and cardiovascular health: Findings from the Dutch MyHeart Counts study (Preprint)

    by Jasper Wilhelmus Adrianus van Egeraat, Anna V Silven, Niels Chavannes, Tobias N. Bonten

    BACKGROUND Fitness and physical activity patterns are key predictors of cardiovascular disease. Traditionally, these factors have been assessed through participant self-report, which is prone to recall bias and inaccuracy. Smartphone-based monitoring provides a scalable and objective alternative for measuring physical activity, offering improved accuracy over conventional assessment methods. OBJECTIVE To evaluated the feasibility of smartphone-based cardiovascular research in the Netherlands and to examine associations between objectively measured physical activity, perceived activity, functional capacity, life satisfaction, and cardiovascular risk. METHODS Adults in the Netherlands were recruited via the MyHeart Counts iPhone app between August 2022 and December 2023. Within the app, participants completed surveys, passively shared motion sensor data, and were invited to perform a smartphone-based 6-minute walk test (6MWT). Perceived activity was compared with sensor-measured activity and actual activity (sensor-measured with supplemented self-reported unrecorded activity). Multivariable linear regression assessed associations between activity and 6MWT performance and between activity and life satisfaction. Perceived cardiovascular risk was compared with the difference between heart age and actual age. RESULTS Of 518 enrolled participants (median age 58 years; 72% female), 93% shared data beyond demographics. Median engagement duration was 27 days, and 58% completed at least one full consecutive week of motion tracking. Perceived activity weakly correlated with both sensor-measured activity (ρ = 0.15, P = .01) and with actual activity (ρ = 0.15, P = .01). Median perceived activity was 3.5 hours/week, significantly higher than sensor-measured activity (0.9 hours/week; mean difference 2.9 hours, 95% CI 2.2–3.7; P < .001). In contrast, median actual activity was 3.2 hours/week and did not differ significantly from perceived activity (mean difference 0.7 hours, 95% CI −0.2 to 1.6; P = .11), indicating no significant over- or underestimation when unrecorded activity was accounted for. Sensor-measured physical activity was associated with longer 6MWT distance (+10.1 m per hour; 95% CI 3.9-16.4, P = 0.002). No association was observed between sensor-measured activity and life satisfaction. Perceived cardiovascular risk correlated with the difference between heart age and actual age (ρ = 0.41; P < 0.001). CONCLUSIONS Smartphone-based cardiovascular monitoring is feasible in a European adult population and yields valid functional correlates of physical activity. However, incomplete phone carriage substantially limits sensor-only activity estimates, underscoring the need for hybrid measurement strategies. These findings support the use of smartphone platforms for scalable cardiovascular research, while highlighting persistent challenges in engagement and measurement completeness.

  • COVID-19’s impact on the future of digital health technology in primary care

    by Nicoline E van Hattem, Anna V Silven, Tobias N Bonten, Niels H Chavannes


  • Open Access

    Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project

    by Ebru Dirikgil, Rick Roos, Geert H. Groeneveld, Christian Heringhaus, Anna V. Silven, Annelieke H.J. Petrus, Maria Villalobos-Quesada, Roula Tsonaka, Paul J.M. van der Boog, Ton J. Rabelink, et al.

    Bronchodilator response (BDR) testing is used as a diagnostic method in obstructive airway diseases. The aim of this investigation was to compare different methods for measuring BDR in participants with asthma and COPD and to study to the extent to which BDR was related to symptom burden and phenotypic characteristics. Forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) was measured before and 15 min after 200 μg of salbutamol in 35 628 subjects aged 16 years and older from three large international population studies. The subjects were categorised in three groups: current asthma (n=2833), COPD (n=1146), and no airway disease (n=31 649). Three definitions for flow related (increase in FEV1) and three for volume related (increase in FVC) were used. The prevalence of bronchodilator reversibility expressed as increase FEV1≥12% and 200 mL was 17.3% and 18.4% in participants with asthma and COPD, respectively, while the corresponding prevalence was 5.1% in those with no airway disease. In asthma, bronchodilator reversibility was associated with wheeze (OR (95% CI): 1.36 (1.04–1.79)), atopy (OR 1.36 (1.04–1.79)) and higher FeNO while in COPD neither flow nor volume related bronchodilator reversibility was associated with symptom burden, exacerbations or health status after adjusting for prebronchodilator FEV1. Bronchodilator reversibility was at least as common in participants with COPD as those with asthma. This indicates that measures of reversibility are of limited value for distinguishing asthma from COPD in population studies. In asthma, however, bronchodilator reversibility may be a phenotypic marker.


  • Open Access

    Telemonitoring for Patients With COVID-19: Recommendations for Design and Implementation

    by Anna V Silven, Annelieke H J Petrus, María Villalobos-Quesada, Ebru Dirikgil, Carlijn R Oerlemans, Cyril P Landstra, Hileen Boosman, Hendrikus J A van Os, Marco H Blanker, Roderick W Treskes, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet


  • Open Access

    Telemonitoring for Patients With COVID-19: Recommendations for Design and Implementation (Preprint)

    by Anna V Silven, Annelieke H J Petrus, María Villalobos-Quesada, Ebru Dirikgil, Carlijn R Oerlemans, Cyril P Landstra, Hileen Boosman, Hendrikus J A van Os, Marco H Blanker, Roderick W Treskes, et al.

    UNSTRUCTURED Despite significant efforts, the COVID-19 pandemic has put enormous pressure on health care systems around the world, threatening the quality of patient care. Telemonitoring offers the opportunity to carefully monitor patients with a confirmed or suspected case of COVID-19 from home and allows for the timely identification of worsening symptoms. Additionally, it may decrease the number of hospital visits and admissions, thereby reducing the use of scarce resources, optimizing health care capacity, and minimizing the risk of viral transmission. In this paper, we present a COVID-19 telemonitoring care pathway developed at a tertiary care hospital in the Netherlands, which combined the monitoring of vital parameters with video consultations for adequate clinical assessment. Additionally, we report a series of medical, scientific, organizational, and ethical recommendations that may be used as a guide for the design and implementation of telemonitoring pathways for COVID-19 and other diseases worldwide.